24-MONTH ANALYSIS FROM PRIME, A PHASE 1B STUDY IN PATIENTS WITH PRODROMAL/MILD ALZHEIMER’S DISEASE
Author(s) -
Philip von Rosenstiel,
Sarah Gheuens,
John O’Gorman,
Ping-Chun Chiao,
C. Hock,
Roger M. Nitsch,
Samantha Budd Haeberlein,
Alfred Sandrock
Publication year - 2018
Publication title -
innovation in aging
Language(s) - English
Resource type - Journals
ISSN - 2399-5300
DOI - 10.1093/geroni/igy023.494
Subject(s) - placebo , tolerability , medicine , cohort , incidence (geometry) , clinical trial , surgery , gastroenterology , adverse effect , pathology , physics , alternative medicine , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom